Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 24
Phase 31

Trial Status

Completed3
Other1

Role Distribution

Principal Investigator2
Other Roles2
PI Rate50%

Activity Timeline

Clinical Trials (4)

NCT04800367Phase 2Active Not Recruiting
Romosozumab/Denosumab Study for Premenopausal IOP
Premenopausal Idiopathic Osteoporosis
PrincipalinvestigatorStart date: 2021-03-12
NCT02049866Phase 2Completed
Denosumab for Prevention of Post-Teriparatide Bone Loss in Premenopausal Women With IOP
Adult Idiopathic Generalized Osteoporosis
PrincipalinvestigatorStart date: 2014-11-19
NCT01440803Phase 2Completed
Forteo Trial on Idiopathic Osteoporosis in Premenopausal Women
Adult Idiopathic Generalized Osteoporosis
StudydirectorStart date: 2012-08-02
NCT00697463Phase 2/3Completed
Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women
FractureMenopauseOsteoporosis
StudydirectorStart date: 2008-08-20

Research Network

Collaboration Network

4 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Elizabeth Shane, MD

Columbia University

Similar
6 trials

Shared therapeutic areas:

Adult Idiopathic Generalized OsteoporosisOsteoporosisFracture+2 more

Worked with same sponsors:

AmgenColumbia University+4 more
Collaborated on 4 trials
Similarity Score66%

Emily M Stein, MD

Columbia University

Related
2 trials

Shared therapeutic areas:

Adult Idiopathic Generalized OsteoporosisOsteoporosis

Worked with same sponsors:

Columbia UniversityElizabeth Shane+1 more
Collaborated on 1 trial
Similarity Score24%

Oke Anakwenze, MD

Duke Department of Orthopedic Surgery

Related
1 trials

Shared therapeutic areas:

Fracture
Similarity Score6%

Olimpia Raftopoulou, MD

Registrat B', Medical State Site, Myrsini, Perfecture of Ilia

Related
1 trials

Shared therapeutic areas:

Osteoporosis
Similarity Score6%

Angelo Di Giunta, MD

Policlinico Morgagni

Related
1 trials

Shared therapeutic areas:

Fracture
Similarity Score6%

Scott Trenhaile, MD

OrthoIllinois

Related
1 trials

Shared therapeutic areas:

Fracture
Similarity Score6%

Jorn Steinbeck, MD

Orthopadische Praxisklinik Von Vincke

Related
1 trials

Shared therapeutic areas:

Fracture
Similarity Score6%

Richard Friedman, MD

Charleston Orthopaedic Associates

Related
1 trials

Shared therapeutic areas:

Fracture
Similarity Score6%

Aristeidis Kerasiotis, Endocrinologist

Director of Endocrinology Unit ,'Iaso' Hospital of Athens, 37-39 Kifisias avenue, 15123, Athens, Greece

Related
1 trials

Shared therapeutic areas:

Osteoporosis
Similarity Score6%

Andreas Sotiriou, Orthop.

Private Office, Zografou, Athens

Related
1 trials

Shared therapeutic areas:

Osteoporosis
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT04800367Phase 2PrincipalInvestigator

Romosozumab/Denosumab Study for Premenopausal IOP

Premenopausal Idiopathic Osteoporosis
Active Not Recruiting
NCT02049866Phase 2PrincipalInvestigator

Denosumab for Prevention of Post-Teriparatide Bone Loss in Premenopausal Women With IOP

Adult Idiopathic Generalized Osteoporosis
Completed
NCT01440803Phase 2StudyDirector

Forteo Trial on Idiopathic Osteoporosis in Premenopausal Women

Adult Idiopathic Generalized Osteoporosis
Completed
NCT00697463Phase 2/3StudyDirector

Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women

FractureMenopauseOsteoporosis
Completed

All 4 trials loaded